Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Gilead Sciences (NQ:GILD)

111.04 -1.01 (-0.90%)
Streaming Delayed Price Updated: 3:49 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,947,168
Open 112.00
Bid (Size) 111.03 (1)
Ask (Size) 111.06 (2)
Prev. Close 112.05
Today's Range 110.70 - 112.86
52wk Range 62.07 - 119.96
Shares Outstanding 1,253,809,440
Dividend Yield 2.77%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Intel's New CEO Outlines Recovery Strategy. Wall Street Remain Cautious.
Intel's new CEO, Lip-Bu Tan, offered his strategy for turning around the troubled chipmaker in a speech late Monday. But Intel stock fell. 
Via Investor's Business Daily
1 Healthcare Stock to Target This Week and 2 to Turn Down
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities

Performance

YTD
+20.9%
+20.9%
1 Month
-4.3%
-4.3%
3 Month
+20.7%
+20.7%
6 Month
+32.4%
+32.4%
1 Year
+52.4%
+52.4%

More News

Read More
If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today
Via Benzinga
What Analysts Are Saying About Gilead Sciences Stock
Via Benzinga
A Closer Look at Gilead Sciences's Options Market Dynamics
Via Benzinga
Merck's Biggest Moneymaker Could Get Even Bigger. But Will It Help Downtrodden Shares?
Via Investor's Business Daily
Exposures Product Safety
No Quick Fix For This Market
Via Talk Markets
Topics Stocks / Equities
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
Via Benzinga
Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Which S&P500 stocks are gapping on Thursday?
Via Chartmill
Gilead Stock Wobbles On Federal HIV Funding Cut Buzz, But Retail And Analysts Stay Unfazed
Via Stocktwits
Stay informed with the top movers within the S&P500 index on Wednesday.
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill
Which S&P500 stocks are gapping on Wednesday?
Via Chartmill
Gilead Dives As HHS Reportedly Mulls Cutting HIV Prevention Funding
Via Investor's Business Daily
Wednesday's pre-market session: top gainers and losers in the S&P500 index
Via Chartmill
Crypto Mixed Post Trump-Putin Call; Trump Eyes HIV Program Cuts, Gilead Dips; Nvidia's AI Lead Secure Through 2028, Says JPMorgan – Top Headlines While The U.S. Slept
Via Benzinga
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
Trump Administration Weighs Deep Cuts To Domestic HIV Prevention Programs, Gilead Stock Slides
Via Benzinga
Topics Government
Exposures Political
A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Unpacking the Latest Options Trading Trends in Gilead Sciences
Via Benzinga
Gilead Sciences - Leader In HIV Medicines
Via Talk Markets
Topics Stocks / Equities
Exposures COVID-19
Friday's session: top gainers and losers in the S&P500 index
Via Chartmill
Is Gilead Sciences Gaining or Losing Market Support?
Via Benzinga
GILEAD SCIENCES INC (NASDAQ:GILD) Exhibits Quality Stock Traits. Here's Why.
Via Chartmill
Gilead Presents New HIV Treatment And Cure Research Data
Via Benzinga

Frequently Asked Questions

Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 111.04
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 04/01/25 03:49 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 139.22B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 139B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.